Get the Stockscreener App
4.89
9.40%
0.42
Organogenesis Holdings Inc stock is traded at $4.89, with a volume of 1.26M.
It is up +9.40% in the last 24 hours and up +1.45% over the past month.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
See More
Previous Close:
$4.47
Open:
$4.54
24h Volume:
1.26M
Relative Volume:
1.49
Market Cap:
$620.33M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
136.97
EPS:
0.0357
Net Cash Flow:
$6.55M
1W Performance:
+3.38%
1M Performance:
+1.45%
6M Performance:
+52.34%
1Y Performance:
+77.82%
1-Day Range:
$4.51
$4.945
1-Week Range:
$4.41
$4.945
52-Week Range:
$2.455
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Name
Organogenesis Holdings Inc
Sector
Phone
781-575-0775
Address
85 DAN ROAD, CANTON, MA
Compare ORGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.89 | 581.01M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Lake Street | Buy |
| Feb-07-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-15-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-24-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-10-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-10-20 | Initiated | SVB Leerink | Outperform |
| Aug-26-19 | Resumed | Credit Suisse | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
| Apr-17-19 | Initiated | Oppenheimer | Outperform |
| Apr-11-19 | Initiated | SunTrust | Buy |
View All
Organogenesis Holdings Inc Stock (ORGO) Latest News
Short Interest Drops in Organogenesis Holdings Inc. After RallyJuly 2025 Final Week & Smart Investment Allocation Insights - newsyoung.net
Applying Elliott Wave Theory to Organogenesis Holdings Inc.July 2025 Momentum & Verified Momentum Watchlists - Newser
Amniotic Membrane Market Poised for Boom Featuring Smith & - openPR.com
Momentum divergence signals in Organogenesis Holdings Inc. chartWeekly Profit Analysis & Weekly Market Pulse Alerts - Newser
Visual trend scoring systems applied to Organogenesis Holdings Inc.Rate Cut & Low Drawdown Trading Techniques - Newser
What data driven models say about Organogenesis Holdings Inc.’s futureQuarterly Market Summary & Weekly Chart Analysis and Trade Guides - Newser
Analyzing recovery setups for Organogenesis Holdings Inc. investorsJuly 2025 Short Interest & Consistent Income Trade Recommendations - Newser
Using fundamentals and technicals on Organogenesis Holdings Inc.2025 Historical Comparison & Weekly Top Gainers Trade List - Newser
Implied Analyst Target Price of $70.96 for iShares Morningstar Small-Cap ETF (ISCB) Suggests 16% Gain Potential. - AInvest
Technical analysis overview for Organogenesis Holdings Inc. stockWeekly Profit Recap & AI Driven Price Predictions - Newser
What analysts say about Organogenesis Holdings Inc. stock outlook2025 Buyback Activity & Free AI Powered Buy and Sell Recommendations - beatles.ru
Can you recover from losses in Organogenesis Holdings Inc.Trade Analysis Report & AI Powered Buy/Sell Recommendations - Newser
Published on: 2025-08-19 02:45:29 - newsyoung.net
Published on: 2025-08-18 04:10:54 - Newser
Organogenesis Holdings Inc. Stock Support and Resistance Levels You Should Know2025 Performance Recap & Fast Entry High Yield Tips - Newser
Reversal indicators forming on Organogenesis Holdings Inc. stock2025 Growth vs Value & Weekly Watchlist for Hot Stocks - Newser
Published on: 2025-08-17 16:03:11 - Newser
How to track smart money flows in Organogenesis Holdings Inc.July 2025 Market Mood & Weekly High Potential Stock Alerts - Newser
How Organogenesis Holdings Inc. stock performs during market volatilityTrade Exit Summary & Technical Confirmation Trade Alerts - Newser
What technical models suggest about Organogenesis Holdings Inc.’s comebackMarket Activity Summary & Consistent Profit Focused Trading Strategies - Newser
Is Organogenesis Holdings Inc. reversing from oversold territoryRisk Management & Long-Term Safe Investment Ideas - Newser
Market reaction to Organogenesis Holdings Inc.’s recent newsBuy Signal & Reliable Volume Spike Trade Alerts - Newser
Wyckoff Accumulation Phase Possible in Organogenesis Holdings Inc.July 2025 Spike Watch & Expert Verified Movement Alerts - kangso.co.kr
Published on: 2025-08-13 08:16:18 - Newser
August 2025's Top Growth Stocks With Strong Insider Confidence - simplywall.st
Is Organogenesis Holdings Inc. stock entering bullish territoryFree Entry Alert Based on Volume Spikes - Newser
Will Organogenesis Holdings Inc. outperform during market ralliesTop High Return Intraday Stocks - thegnnews.com
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2025 Earnings Call Transcript - Insider Monkey
What makes Organogenesis Holdings Inc. stock price move sharplyAI Swing Strategy Signal Forecasting System - Newser
Cantor Fitzgerald maintains Overweight rating on Organogenesis stock By Investing.com - Investing.com Canada
Cantor Fitzgerald maintains Overweight rating on Organogenesis stock - Investing.com
Organogenesis Holdings Inc Stock (ORGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Organogenesis Holdings Inc Stock (ORGO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 05 '25 |
Buy |
2.91 |
142,379 |
413,625 |
837,437 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 04 '25 |
Buy |
2.82 |
100,863 |
284,716 |
695,058 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 06 '25 |
Buy |
2.99 |
9,022 |
26,949 |
846,459 |
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):